BRG1通过ZFP91介导NIK/NF-κB信号轴促进胆囊癌早期转移的分子机制研究
批准号:
82203782
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
胡海洁
依托单位:
学科分类:
肿瘤复发与转移
结题年份:
2025
批准年份:
2022
项目状态:
已结题
项目参与者:
--
中文摘要
胆囊癌因极早转移而预后很差。上皮间质转化(EMT)是上皮肿瘤侵袭转移的关键细胞学行为,涉及大量基因的异常转录,与染色质重塑机制紊乱有关。我们发现染色质重塑复合体SWI/SNF关键亚基BRG1在发生早期转移的胆囊癌中高表达并提示更差预后。体外实验证实BRG1明显促进胆囊癌细胞EMT。RNA-seq提示NF-κB通路相关基因在BRG1高表达组织中升高,而Wnt、Hippo、Notch等变化不明显。NF-κB主要激活细胞因子、炎症介质,是炎症相关肿瘤(如胆囊癌)的重要促进因子。进一步发现NF-κB的经典激活途径并没有活化,相反非经典途径关键因子NIK、p52等明显升高。该途径受ZFP91的调控,而ZFP91则可能是BRG1的靶基因。我们推测BRG1/ZFP91/NIK/NF-κB信号轴在胆囊癌EMT中至关重要,本研究将验证该假设,揭示胆囊癌独特的EMT机制,为合理干预其早期转移提供理论支持。
英文摘要
Gallbladder cancer has a poor prognosis mainly due to early intrahepatic or lymph node metastasis. Epithelial-mesenchymal transformation (EMT) is a key cytological factor for the invasive and metastatic process of epithelial tumors. A large number of genes are abnormally transcribed during EMT, which is closely correlated with the dysfunction of the chromatin remodeling complex. We found that BRG1, a key subunit of SWI/SNF complex, was overexpressed in metastatic gallbladder cancer, especially in those with early metastasis. High-BRG1 expression was associated with a poorer prognosis. BRG1 could significantly promote EMT and metastasis in gallbladder cancer cells. RNA-seq showed that NF-κB pathway related genes were significantly increased in patients with high-BRG1 expression, while Wnt, Hippo, Notch and other pathway-related genes were not significantly changed. NF-κB pathway mainly activates cytokines and inflammatory mediators and is an important promoter of the inflammation-related tumors such as gallbladder cancer. We further found the canonical pathway of NF-κB was not activated during the process, whereas the noncanonical pathway related genes, such as NIK and p52 were significantly increased. This pathway was regulated by ZFP91, which might be a target gene of BRG1. Thus, we speculated that the BRG1/ZFP91/NIK/NF-κB pathway was crucial in the EMT and metastasis of gallbladder cancer. This study will verify this hypothesis and reveal the unique EMT mechanism of gallbladder cancer, providing a theoretical support for the intervention of early metastasis of gallbladder cancer.
项目背景: 胆囊癌(GBC)是最常见的胆道系统恶性肿瘤,具有恶性程度高、早期易转移的特点,患者预后极差。上皮-间质转化(EMT)在其侵袭转移中起关键作用。染色质重塑复合体核心组分BRG1(SMARCA4)在多种肿瘤EMT及转移中扮演重要角色,但其在胆囊癌中的功能及机制尚未阐明。.主要研究内容: 本项目旨在探究BRG1在胆囊癌EMT及早期转移中的作用及具体分子机制。研究内容主要包括:1) 利用临床样本、细胞系及类器官模型,明确BRG1表达与胆囊癌临床病理特征、EMT指标及NF-κB信号通路活化的相关性;2) 通过构建裸鼠荷瘤、肝转移及肺转移模型,验证BRG1对胆囊癌体内转移能力的影响;3) 采用ATAC-seq、ChIP-seq、RNA-seq等多组学技术及分子生物学实验,深入解析BRG1通过调控锌指蛋白ZFP91,进而激活NIK/NF-κB非经典信号通路,最终驱动EMT及转移的级联机制;4) 评估基于BRG1抑制剂的靶向治疗策略在胆囊癌中的潜在应用价值。.重要结果与关键数据: 1) 临床分析发现,BRG1在胆囊癌组织中显著高表达,且与淋巴结转移、早期转移、术后复发及不良预后显著正相关。2) 体内外功能实验证实,沉默BRG1可显著抑制胆囊癌细胞迁移、侵袭、EMT表型及裸鼠肺转移结节形成。3) 机制研究表明,BRG1通过转录调控上调ZFP91表达;ZFP91作为E3泛素连接酶稳定并激活NIK,进而驱动NF-κB非经典通路(p100/p52)活化,最终促进EMT关键分子(如Snail、Vimentin)表达并抑制E-cadherin。4) 基于BRG1晶体结构虚拟筛选出的小分子抑制剂(NO.9, NO.11)在体外能有效抑制胆囊癌细胞及类器官生长。.科学意义: 本研究首次系统地揭示了BRG1/ZFP91/NIK/NF-κB信号轴在胆囊癌EMT及早期转移中的关键作用,从染色质重塑与转录调控层面深化了对胆囊癌高转移特性的认识。所发现的BRG1作为预后生物标志物的潜力及其调控的分子通路,为胆囊癌的早期诊断提供了新思路。更为重要的是,研究证实靶向BRG1具有抗胆囊癌治疗前景,为开发针对此恶性疾病的新型靶向治疗策略奠定了坚实的理论与实验基础。
BRG1通过ZFP91介导NIK/NF-κB信号轴促进胆囊癌早期转移的分子机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:胡海洁
-
依托单位:
国内基金
海外基金